Definium Therapeutics (DFTX) Net Income towards Common Stockholders (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.86% |
| Dec 31, 2025 | 25.02% |
| Sep 30, 2025 | -57.37% |
| Jun 30, 2025 | -40.85% |
| Mar 31, 2025 | 12.65% |
| Dec 31, 2024 | -57.60% |
| Sep 30, 2024 | -14.22% |
| Jun 30, 2024 | 64.52% |
| Mar 31, 2024 | -152.91% |
| Dec 31, 2023 | -6.61% |
| Sep 30, 2023 | 27.61% |
| Jun 30, 2023 | -42.37% |
| Mar 31, 2023 | -134.43% |
| Dec 31, 2022 | 444.92% |
| Sep 30, 2022 | 2.78% |
| Jun 30, 2022 | 8.37% |
| Mar 31, 2022 | -166.70% |
| Dec 31, 2021 | 261.34% |
| Sep 30, 2021 | 62.00% |
| Jun 30, 2021 | -204.83% |
| Mar 31, 2021 | -2,079.33% |
| Dec 31, 2020 | 108.65% |
| Sep 30, 2020 | -51.74% |
| Jun 30, 2020 | 18.71% |
| Mar 31, 2020 | 34.26% |